News for 'ivax'

Indian company best fit for Merck Generics

The Indian company that acquires Merck Generics, the multinational drug maker's generics (non-patented) business, up for sale, will be able to compete against the top global players

Global drug giants rediscover India

Ranbaxy loses exclusivity on heartburn drug in US

FDA allows Teva to launch Nexium generic; Cipla, which supplies formulation, to gain

'Premature to talk of changes in Ranbaxy top brass now'

Sun Pharmaceutical Industries will take a call on whether to shut Ranbaxy's troubled factories or make changes in the top management of the latter only after its $4-billion acquisition deal is complete.